Cargando…

Retrovectors packaged in CHO cells to generate GLP-1-Fc stable expression CHO cell lines

BACKGROUND: Chinese hamster ovary (CHO) cells are the most dependable mammalian cells for the production of recombinant proteins. Replication-incompetent retroviral vector (retrovector) is an efficient tool to generate stable cell lines. Multiple copies of integrated genes by retrovector transductio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jing, Wei, Suzhen, Cao, Chunlai, Chen, Kangyue, He, Hua, Gao, Guoquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pontificia Universidad Católica de Valparaíso. Production and hosting by Elsevier B.V. 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125944/ https://www.ncbi.nlm.nih.gov/pubmed/32288149 http://dx.doi.org/10.1016/j.ejbt.2019.07.002

Ejemplares similares

CHO cell lines generated by PiggyBac transposition
por: Matasci, Mattia, et al.
Publicado: (2011)

Toolbox approach for fast generation of stable CHO production cell lines from different hosts
por: Seitz, Susanne, et al.
Publicado: (2011)

Next-generation sequencing of the CHO cell transcriptome
por: Becker, Jennifer, et al.
Publicado: (2011)

Robotic selection for the rapid development of stable CHO cell lines for HIV vaccine production
por: O’Rourke, Sara M., et al.
Publicado: (2018)

Understanding and Controlling Sialylation in a CHO Fc-Fusion Process
por: Lewis, Amanda M., et al.
Publicado: (2016)

Establishment of a stable CHO cell line with high level expression of recombinant porcine IFN-β
por: Chen, Weiye, et al.
Publicado: (2011)

Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen
por: Nyon, Mun Peak, et al.
Publicado: (2018)

Influence of cell culture media and feed supplements on cell metabolism and quality of IgG produced in CHO-K1, CHO-S, and CHO-DG44
por: Reinhart, David, et al.
Publicado: (2015)

The engineered expression of secreted HSPB5-Fc in CHO cells exhibits cytoprotection in vitro
por: Li, Jing, et al.
Publicado: (2021)

Engineering CHO cell growth by stable manipulation of miRNA expression
por: Sanchez, Noëlia, et al.
Publicado: (2011)

Development of a CHO cell line for stable production of recombinant antibodies against human MMP9
por: Ryu, Jina, et al.
Publicado: (2022)

Cre-mediated cellular modification for establishing producer CHO cells of recombinant scFv-Fc
por: Kawabe, Yoshinori, et al.
Publicado: (2015)

The Use of Transcription Terminators to Generate Transgenic Lines of Chinese Hamster Ovary Cells (CHO) with Stable and High Level of Reporter Gene Expression
por: Gasanov, N. B., et al.
Publicado: (2015)

Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies
por: Chung, Nancy PY, et al.
Publicado: (2014)

Impact on product quality of high productive GS-CHO cell lines
por: Perani, Angelo, et al.
Publicado: (2011)

CHO starter cell lines for manufacturing of proteins with pre-defined glycoprofiles
por: Winkler, Karsten, et al.
Publicado: (2013)

Rich production media as a platform for CHO cell line development
por: Kim, Yong Jae, et al.
Publicado: (2020)

Novel application of anti‐human Fc nanobody for screening high‐producing CHO cells for monoclonal antibody
por: Zhu, Di, et al.
Publicado: (2022)

Construction of transgene-amplified CHO cell lines by cell cycle checkpoint engineering
por: Lee, Kyoung Ho, et al.
Publicado: (2013)

Influence of glutamine on transient and stable recombinant protein production in CHO and HEK-293 cells
por: Rajendra, Yashas, et al.
Publicado: (2011)

Stable overexpression of miR-17 enhances recombinant protein production of CHO cells()
por: Jadhav, Vaibhav, et al.
Publicado: (2014)

Production and purification of TGFb-1 in CHO-Cells
por: Abdulkerim, Estabraq, et al.
Publicado: (2011)

Engineering CHO cell metabolism for growth in galactose
por: Jiménez, Natalia E, et al.
Publicado: (2011)

Controllability Analysis of Protein Glycosylation in Cho Cells
por: St. Amand, Melissa M., et al.
Publicado: (2014)

Hyperosmolality in CHO cell culture: effects on the proteome
por: Romanova, Nadiya, et al.
Publicado: (2022)

Development of a pre-glycoengineered CHO-K1 host cell line for the expression of antibodies with enhanced Fc mediated effector function
por: Popp, Oliver, et al.
Publicado: (2017)

Generation of genetically engineered CHO cell lines to support the production of a difficult to express therapeutic protein
por: Laux, Holger, et al.
Publicado: (2013)

The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line
por: Xu, Xun, et al.
Publicado: (2011)

Characterization of recombinant IgA producing CHO cell lines by qPCR
por: Reinhart, David, et al.
Publicado: (2013)

Expression of soluble, active, fluorescently tagged hephaestin in COS and CHO cell lines
por: ASLAN, Elif Sibel, et al.
Publicado: (2020)

Design of a stable cell line producing a recombinant monoclonal anti-TNFα antibody based on a CHO cell line
por: Voronina, E. V., et al.
Publicado: (2016)

Rapid recombinant protein production from pools of transposon-generated CHO cells
por: Matasci, Mattia, et al.
Publicado: (2011)

Stable Expression of Recombinant Factor VIII in CHO Cells Using Methotrexate-Driven Transgene Amplification
por: Orlova, N. A., et al.
Publicado: (2012)

Functional Trimeric SARS-CoV-2 Envelope Protein Expressed in Stable CHO Cells
por: Mayrhofer, Patrick, et al.
Publicado: (2021)

Development of a stable antibody production system utilizing an Hspa5 promoter in CHO cells
por: Tanemura, Hiroki, et al.
Publicado: (2022)

Intraclonal Protein Expression Heterogeneity in Recombinant CHO Cells
por: Pilbrough, Warren, et al.
Publicado: (2009)

Engineering of CHO cells for the production of vertebrate recombinant sialyltransferases
por: Houeix, Benoit, et al.
Publicado: (2019)

Metabolic Profiling of CHO Cells during the Production of Biotherapeutics
por: Coulet, Mathilde, et al.
Publicado: (2022)

CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immune responses against SARS-CoV-2
por: Laotee, Sedthawut, et al.
Publicado: (2023)

Manipulation of mRNA translation elongation influences the fragmentation of a biotherapeutic Fc‐fusion protein produced in CHO cells
por: Knight, Tanya J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p7g7k7ab8jm0irf5k8j1938vn7